Induction of fetal hemoglobin as a novel therapeutic strategy for β-hemoglobinopathy.
Department of Hematology and Blood Banking, Tarbiat Modares University, Tehran, Iran.
Ali Dehghani
AD
Fard
Department of Hematology and Blood Banking, Tarbiat Modares University, Tehran, Iran.
Saeid
S
Kaviani
Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Mehrdad
M
Noruzinia
Thalassemia and Hemoglobinopathy Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran.
Najmaldin
N
Saki
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.
Esmaeil
E
Mortaz
D000755:Anemia, Sickle Cell / Q000188:drug therapy / Q000378:metabolism; D020533:Angiogenesis Inhibitors / Q000819:agonists / Q000627:therapeutic use*; D000818:Animals; D020148:Butyric Acid / Q000819:agonists / Q000627:therapeutic use*; D004357:Drug Synergism; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D006633:Histamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D013792:Thalidomide / Q000819:agonists / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000188:drug therapy / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D006633:Histamine Antagonists; D020148:Butyric Acid; D013792:Thalidomide; D005319:Fetal Hemoglobin